INSIGHTS ON DRUG DEVELOPMENT
-
Rapid Automated Selection Of Mammalian Cell Colonies
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
-
Non Animal Origin Squalene For High-Risk Applications
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Improving Next-Generation Sequencing Workflows With Droplet Digital PCR
Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.
-
Accelerate Your pDNA And mRNA Process Development
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Seed Train Intensification Using High Cell Density Cryopreservation8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
The Role Of A Consulting Firm In The IND Process6/10/2025
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Unlock The Power Of Biophysical Tools In Biotherapeutic Development7/15/2025
Unlock innovation in biotherapeutics with expert insights into DSC and molecular stability. Learn how biophysical techniques can optimize formulations and enhance nucleic acid stability.
-
The Role Of CDMOs In Supporting Generic Drug Development7/15/2025
Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.
DRUG DEVELOPMENT SOLUTIONS
-
Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
-
Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.
-
Understand Your Biotransformation Data
MetaSense helps you make sense of all your metabolite identification (MetID) data. Move beyond complex workflows that have you flipping back and forth between a dozen programs.
With a single interface for prediction, data analysis, and knowledge dashboards, make data-driven decisions swiftly.
- Collect all your MetID data and view it in one place
- Auto-generate biotransformation maps and kinetic plots
- Click between interactively linked maps and plots to see your data at any depth
- Reprocess data directly from MetaSense
- Draw conclusions about a drug candidate’s metabolism and viability
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.